Polarean Imaging (LSE:POLX) has formalized a Representative Agreement with Ascend Imaging to promote and distribute its cutting-edge Xenon MRI platform across four US states. This collaboration is set to boost Polarean’s commercial presence and support its strategic growth ambitions in the competitive American healthcare market.
By tapping into Ascend Imaging’s radiology expertise and established customer base, Polarean aims to increase adoption of its innovative MRI technology designed for enhanced lung function visualization.
About Polarean Imaging
Polarean Imaging specializes in advanced medical imaging solutions with a focus on pulmonary health. Its flagship product, the FDA-cleared XENOVIEW®, utilizes hyperpolarized Xenon gas as a contrast agent to enable non-invasive, radiation-free lung MRI scans. The technology addresses the needs of over 500 million patients worldwide suffering from chronic respiratory conditions, representing a major advancement in pulmonary diagnostics.
Leave a Reply